A

ADARx

HealthsiRNA

ADARx is a startup focused on siRNA technology. The company has successfully raised $446.3 million through an IPO, indicating significant investor confidence in its potential within the biotechnology sector.

Total raised
Undisclosed
tracked to date
Latest round
IPO
Sep 25, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    $446.3MIPOSep 25, 2026
    Announcement ↗

ADARx in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile